FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold. The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold. Business
The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.
Read more on NPR